Similar articles

• Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type.

  Stefanini GF, Prati E, Albini MC, Piccinini G, Capelli S, Castelli E, Mazzetti M, Gasbarrini G. Stefanini GF, et al. Am J Gastroenterol. 1992 Jan;87(1):55-7. Am J Gastroenterol. 1992. PMID: 1728124
• [Irritable colon syndrome in intolerance to food additives].

  Antico A, Soana R, Clivio L, Baioni R. Antico A, et al. Minerva Dietol Gastroenterol. 1989 Oct-Dec;35(4):219-24. Minerva Dietol Gastroenterol. 1989. PMID: 2516298 Italian.
• Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients.

  Stefanini GF, Saggioro A, Alvisi V, Angelini G, Capurso L, di Lorenzo G, Dobrilla G, Dodero M, Galimberti M, Gasbarrini G, et al. Stefanini GF, et al. Scand J Gastroenterol. 1995 Jun;30(6):535-41. doi: 10.3109/00365529509089786. Scand J Gastroenterol. 1995. PMID: 7569760 Clinical Trial.
• Tegaserod for the treatment of constipation-predominant irritable bowel syndrome.

  Baker DE. Baker DE. Rev Gastroenterol Disord. 2001;1(4):187-98. Rev Gastroenterol Disord. 2001. PMID: 12120185 Review.
• What is the relevance of a systematic review of pharmacological management in irritable bowel syndrome to older people? Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

  Camilleri M, Kim DY. Camilleri M, et al. J Am Geriatr Soc. 2001 Sep;49(9):1249-52. doi: 10.1046/j.1532-5415.2001.49244.x. J Am Geriatr Soc. 2001. PMID: 11559387 No abstract available.